Published in Tissue Antigens on January 01, 2004
Signatures of human regulatory T cells: an encounter with old friends and new players. Genome Biol (2006) 1.27
Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity. Mediators Inflamm (2009) 1.17
Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med (2001) 7.86
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain (2008) 2.96
Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME). Br J Dermatol (2014) 2.76
The lymphocyte transformation test for the diagnosis of Lyme borreliosis has currently not been shown to be clinically useful. Clin Microbiol Infect (2014) 2.62
Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neurol Scand (2004) 2.52
Novel path to apoptosis: small transmembrane pores created by staphylococcal alpha-toxin in T lymphocytes evoke internucleosomal DNA degradation. Infect Immun (1994) 2.47
Statins as immunomodulators: comparison with interferon-beta 1b in MS. Neurology (2002) 2.34
Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect (2011) 2.23
T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur J Immunol (1993) 1.74
Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Mult Scler (2012) 1.73
Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults. Neurology (2008) 1.62
Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms. Br J Dermatol (1997) 1.60
Cutaneous aspergillosis and acquired immunodeficiency syndrome. Arch Dermatol (2000) 1.55
Decision support software to help primary care physicians triage skin cancer: a pilot study. Arch Dermatol (2000) 1.53
European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr (1996) 1.51
Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J Neurol Sci (2011) 1.49
Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS. Mult Scler (2007) 1.49
Late onset Charcot-Marie-Tooth 2 syndrome caused by two novel mutations in the MPZ gene. Neurology (2003) 1.48
A comparative study of the relative bioavailability of different interferon beta preparations. Neurology (2000) 1.45
Molecular and functional characterization of protein 4.1B, a novel member of the protein 4.1 family with high level, focal expression in brain. J Biol Chem (2000) 1.45
Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia. J Exp Med (1994) 1.33
Differences between Lyme disease and European arthropod-borne Borrelia infections. Lancet (1985) 1.32
Calcium entry through kainate receptors and resulting potassium-channel blockade in Bergmann glial cells. Science (1992) 1.26
Improving primary care residents' proficiency in the diagnosis of skin cancer. J Gen Intern Med (1998) 1.26
Cold shock damage is due to lipid phase transitions in cell membranes: a demonstration using sperm as a model. J Exp Zool (1993) 1.23
Real-time sonoelastography: findings in patients with symptomatic achilles tendons and comparison to healthy volunteers. Ultraschall Med (2009) 1.23
Smoking is a risk factor for early conversion to clinically definite multiple sclerosis. Mult Scler (2008) 1.19
Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosis. Magn Reson Med (2000) 1.19
Functional properties of AMPA and NMDA receptors expressed in identified types of basal ganglia neurons. J Neurosci (1997) 1.17
Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature. Mult Scler (2011) 1.16
Signaling lymphocytic activation molecule is expressed on mature CD83+ dendritic cells and is up-regulated by IL-1 beta. J Immunol (2001) 1.16
Progressive cerebellar syndrome in adult coeliac disease. J Neurol (1987) 1.14
Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodies. Neurology (1999) 1.11
Anti-myelin antibodies do not allow earlier diagnosis of multiple sclerosis. Mult Scler (2005) 1.11
Blepharochalasis. Br J Ophthalmol (1988) 1.09
Primary care physicians as gatekeepers in managed care. Primary care physicians' and dermatologists' skills at secondary prevention of skin cancer. Arch Dermatol (1996) 1.06
Lipocalin-2 regulates the inflammatory response during ischemia and reperfusion of the transplanted heart. Am J Transplant (2007) 1.06
Clinical applications of techniques used in human in vitro fertilization research. Am J Obstet Gynecol (1983) 1.06
Diffuse white matter damage is absent in neuromyelitis optica. AJNR Am J Neuroradiol (2009) 1.05
The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls. J Neuroimmunol (2001) 1.03
Botulinum A toxin injection in focal hyperhidrosis. Br J Dermatol (1996) 1.02
Neurological and neuropsychiatric spectrum of Wilson's disease: a prospective study of 45 cases. J Neurol (1991) 1.02
Testing for antibodies to human aquaporin-4 by ELISA: sensitivity, specificity, and direct comparison with immunohistochemistry. J Neurol Sci (2012) 1.02
Observations regarding DNA replication sites in human cells in vivo following infusions of iododeoxyuridine and bromodeoxyuridine. Cell Prolif (1991) 1.00
Expression of Fas and Fas ligand after experimental traumatic brain injury in the rat. J Cereb Blood Flow Metab (2000) 1.00
Comparison of techniques for selection of motile spermatozoa. Fertil Steril (1985) 1.00
[Double infection with early summer meningoencephalitis virus and Borrelia burgdorferi]. Dtsch Med Wochenschr (1986) 1.00
The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease. Brain (2000) 0.98
Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event. J Neurol Neurosurg Psychiatry (2006) 0.96
European Lyme borreliosis. Ann N Y Acad Sci (1988) 0.96
Presumptive D2a point mutants of bacteriophage T4. J Virol (1973) 0.95
Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome. Infect Immun (1997) 0.95
Plant polyketide synthases: a chalcone synthase-type enzyme which performs a condensation reaction with methylmalonyl-CoA in the biosynthesis of C-methylated chalcones. Biochemistry (1998) 0.94
Localization of insulin-like growth factor-I (IGF-I) and IGF-I receptor (IGF-IR) in equine testes. Reprod Domest Anim (2011) 0.94
Targeting the Nogo receptor complex in diseases of the central nervous system. Curr Med Chem (2011) 0.93
Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis. Neurology (2001) 0.93
Roussy-Lévy syndrome is a phenotypic variant of Charcot-Marie-Tooth syndrome IA associated with a duplication on chromosome 17p11.2. J Neurol Sci (1998) 0.93
A comparison of magnetization transfer ratio, magnetization transfer rate, and the native relaxation time of water protons related to relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol (2001) 0.92
The thymus and self-tolerance: co-existence of encephalitogenic S100 beta-specific T cells and their nominal autoantigen in the normal adult rat thymus. Int Immunol (1997) 0.92
Adult coeliac disease and brainstem encephalitis. J Neurol Neurosurg Psychiatry (1988) 0.92
Increased expression of apolipoprotein D following experimental traumatic brain injury. J Neurochem (1999) 0.91
Mutations in the gene for toll-like receptor 4 and multiple sclerosis. Tissue Antigens (2003) 0.91
Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis. J Neurol Neurosurg Psychiatry (2000) 0.91
4-Hydroxy-2-pyrone formation by chalcone and stilbene synthase with nonphysiological substrates. Phytochemistry (1998) 0.91
Common superficial fungal infections in patients with AIDS. Clin Infect Dis (1996) 0.91
Glial cell death induced by overexpression of alpha-synuclein. J Neurosci Res (2001) 0.91
Neuroborreliosis in morphea and lichen sclerosus et atrophicus. J Am Acad Dermatol (1988) 0.90
Wilson's disease: evidence of subgroups derived from clinical findings and brain lesions. Neurology (1993) 0.90
Diffusion-weighted MR imaging of the spinal cord. AJNR Am J Neuroradiol (2000) 0.90
Submucous rather than myenteric neurons are activated by mucosal biopsy supernatants from irritable bowel syndrome patients. Neurogastroenterol Motil (2012) 0.90
Myelin oligodendrocyte glycoprotein-DNA vaccination induces antibody-mediated autoaggression in experimental autoimmune encephalomyelitis. Eur J Immunol (2000) 0.89
Comparison of the ability of progesterone and heat solubilized porcine zona pellucida to initiate the porcine sperm acrosome reaction in vitro. Mol Reprod Dev (1994) 0.89
Ganglionitis in paraneoplastic subacute sensory neuronopathy: a morphologic study. Neurology (1997) 0.89
Fluorescent probes and flow cytometry to assess rat sperm integrity and mitochondrial function. Reprod Toxicol (2001) 0.88
Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis. Mult Scler (2001) 0.88
Long-term follow-up in cerebral Whipple's disease. Eur J Gastroenterol Hepatol (1996) 0.88